Clinical Trial Update: Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures [Phase 3]

View source ↗

Summary

Phase 3 pilot trial evaluating redosing liposomal bupivacaine for pain control in major gynecologic procedures has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer
• Uterine Fibroids

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of California, Irvine | Conditions: Ovarian Cancer, Fibroids | Phase 3 | Status: TERMINATED